Original articleMotor and respiratory heterogeneity in Duchenne patients: Implication for clinical trials
Highlights
► We study the phenotypic heterogeneity in Duchenne muscular dystrophy. ► The French DMD database provides clinical and molecular data of 278 patients. ► A severe DMD group has early severe motor and respiratory (but not heart) decline. ► Phenotypic heterogeneity must be considered in the design of clinical trials. ► Same efficacy will be detected by 4 to 6 times fewer patients from severe DMD form.
Introduction
Duchenne Muscular Dystrophy (DMD; MIM#310200) is an inherited X-linked muscular dystrophy caused by mutations in the DMD gene (MIM#300377). The classical description of the disease includes progressive loss of muscle strength beginning between 3 and 5 years old, responsible for loss of ambulation between 9 and 10 years old, associated with dilated cardiomyopathy and respiratory failure in the second decade.1
However, phenotype is not as stereotyped as often imagined.2, 3 Some patients lose ambulation during adolescence, which has led to the individualization of a milder motor phenotype in 1994 named ‘Intermediary Muscular Dystrophy’ (IMD).4 Moreover, a high degree of variability in restrictive respiratory insufficiency was noticed by Rideau et al.5 in 1981. However, no large-scale studies have been reported since then. Precise assessment of the DMD clinical heterogeneity becomes necessary as clinical trials are being planned now. This requires the survey of a large number of patients with a long follow-up.
Databases may help to achieve this objective. In the field of genetic diseases, new generation of locus-specific databases known as knowledge bases6, 7, 8 are recognized as an essential tool, thanks to their exhaustive and high quality data.9 The challenge is now to develop the clinical part of these databases, a crucial step to improve our knowledge about natural history of genetic diseases and phenotype-genotype correlations.
The UMD–DMD France knowledge base collects molecular and clinical data for patients with an identified mutation in the DMD gene at the national level. It currently contains 2 411 mutation records.10 The analysis of 311 clinical criteria describing the disease course for 347 of these DMD or IMD patients, with a mean longitudinal follow-up of more than 12 years, allowed us to better delineate the clinical heterogeneity of DMD, and in particular motor and respiratory involvement in 278 patients in whom age at loss of ambulation was known.
Section snippets
Patients
Currently, UMD–DMD France contains 2411 entries with molecular data corresponding to 2046 male patients and 38 expressing females. These molecular data have been collected through the network of the 14 molecular diagnostic laboratories in charge of the molecular testing of the DMD gene in France.10 Clinical data are in the course of collection through the network of the 11 French national reference centers for neuromuscular diseases. This step has been completed for 527 patients, of whom 332
Results
Clinical, histochemical and molecular data of the three groups of patients (total number of patients: 278) are described in Table 1, Table 2, Table 3, Supplementary Tables 1 and 2 and Supplementary Figures 1 and 2. The age at loss of ambulation was 7.10 ± 0.54 [min 5.25 – max 7.75] years in group A, 9.25 ± 0.81 [min 8.00 – max 10.92] years in group B, 12.01 ± 1.05 [min 11.00 – max 15.75] years in group C. The age at last follow-up was 15.51 ± 6.26 [min 7.5 – max 37] years in group A, 18.48 ± 6.67 [min
Motor function decline, orthopedic complications and respiratory insufficiency are correlated with the age at loss of ambulation
In our cohort, the non-acquisition of some motor abilities, the progressive loss of motor abilities, the severity of limb contractures and the occurrence of scoliosis are well correlated with the age at loss of ambulation. This is in agreement with the well-known facts that limb contractures progress in parallel with the increasing motor deficit and the loss of motor abilities,18 and that scoliosis appears to be most importantly related to the age at loss of ambulation.19, 20, 21 Our results
Conclusion
By analyzing a large cohort with exhaustive clinical data, prolonged longitudinal follow-up and genetically confirmed diagnosis, we observed that DMD phenotype is heterogeneous from the motor, respiratory and survival points of view. Three groups of patients emerged. The larger group has a common DMD presentation. A smaller group that we defined as “severe muscular dystrophy” has a worse clinical presentation, with loss of ambulation before 8 years and earlier and severe respiratory failure.
Acknowledgments
This work is supported by AFM (Association Française contre les Myopathies). VH and DH are the recipients of a grant from AFM. We thank the French network of molecular diagnostic laboratories: Leturcq F. and Chelly J. (Hôpital Cochin, Laboratoire de Biochimie et Génétique Moléculaire, Paris, F-75014, France); Ben Yaou R. (Hôpital Cochin, Laboratoire de Biochimie et Génétique Moléculaire, Paris, F-75014, France; Inserm, U974, Institut de Myologie, GH Pitié-Salpêtrière, Paris, F-75013, France);
References (36)
The muscular dystrophies
Lancet
(2002)- et al.
Genetic mutation databases: stakes and perspectives for orphan genetic diseases
Pathol Biol (Paris)
(2010) - et al.
Muscular dystrophy campaign funded workshop on management of scoliosis in duchenne muscular dystrophy 24 January 2005, London, UK
Neuromuscul Disord
(2006) - et al.
Predictive factors for the development of scoliosis in Duchenne muscular dystrophy
Eur J Paediatr Neurol
(2007) - et al.
Pulmonary function in Duchenne muscular dystrophy related to stage of disease
Am J Med
(1974) - et al.
Clinical implications of maximal respiratory pressure determinations for individuals with Duchenne Muscular dystrophy
Arch Phys Med Rehabil
(1997) - et al.
Lung function in children with Duchenne’s muscular dystrophy
Resp Med
(2001) - et al.
Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy
Neuromuscular Disord
(1996) - et al.
Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: a two-dimensional echocardiographic study
Am Heart J
(1998) - et al.
Functional ability and muscle force in healthy children and ambulant Duchenne muscular dystrophy patients
Eur J Paediatr Neurol
(2005)
Continuous monitoring and quantification of multiple parameters of daily physical activity in ambulatory Duchenne muscular dystrophy patients
Eur J Paediatr Neurol
Clinical investigation in Duchenne dystrophy – 2. Determination of the power of therapeutic trials based on the natural history
Muscle Nerve
Clinical features
Diagnostic criteria for neuromuscular disorders
Respiratory function in the muscular dystrophies
Muscle Nerve
Time for a unified system of mutation description and reporting: a review of locus-specific mutation Databases
Genome Res
Locus-specific database domain and data content analysis: evolution and content maturation toward clinical use
Hum Mutat
The HUGO mutation database initiative
Pharmacogenomics J
Cited by (106)
Pediatric Neuromuscular Diseases
2023, Pediatric NeurologyThe natural history of pulmonary disease
2023, Pulmonary Assessment and Management of Patients with Pediatric Neuromuscular DiseaseLeveraging cardiac magnetic resonance imaging to assess skeletal muscle progression in Duchenne muscular dystrophy
2022, Neuromuscular DisordersCardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges
2022, The Lancet Respiratory MedicineCitation Excerpt :For example, FVC correlates with upper extremity muscle strength such that patients with upper extremity weakness have lower FVC levels.87 Moreover, Humbertclaude and colleagues86 showed that respiratory phenotypic severity can be predicted by age at loss of ambulation—ie, patients with the most impaired lung function over time also have loss of ambulation at the earliest age (the severe phenotype; appendix p 2). Cardiac phenotypes can be categorised by the age at onset of left ventricular dysfunction (LVD).
Trunk-oriented Exercises Versus Whole-body Vibration on Abdominal Thickness and Balance in Children with Duchene Muscular Dystrophy
2024, Journal of Musculoskeletal Neuronal Interactions
- w
These two authors contributed equally to this work.
- x
Present address: CHU Robert Debré, Service de Neurologie Pédiatrique, Paris, F-75935, France.
- y
Present address: 27 rue Jean Macé, Grenoble, F-38000, France.